Kamada Says FDA Approves Kamada Plasma's Collection Center In San Antonio
3/26/2026
Impact: 75
Healthcare
Kamada Ltd. announced that the FDA has approved its plasma collection center in San Antonio, Texas, allowing it to begin commercial sales of normal source plasma. The facility has an annual collection capacity of approximately 50,000 liters and is expected to contribute an estimated annual revenue of $8 million to $10 million at full capacity. It is designed to collect both normal source plasma and specialty plasma, positioning it as one of the largest centers for specialty plasma collection in the U.S.
AI summary, not financial advice
Share: